Pharmacotherapy of borderline personality disorder Review uri icon

Overview

MeSH Major

  • Antidepressive Agents, Second-Generation
  • Borderline Personality Disorder
  • Monoamine Oxidase Inhibitors
  • Serotonin Uptake Inhibitors

abstract

  • Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.

publication date

  • December 1997

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 9418746

Additional Document Info

start page

  • 48

end page

  • 52; discussion 53

volume

  • 58

number

  • SUPPL. 14